Literature DB >> 16612401

Follow-up of patients with contrast-induced nephropathy.

R Solomon1, B Barrett.   

Abstract

In this chapter, we review the approach to following the patient after contrast is administered. We first discuss the clinical importance of renal injury for if there were no clinically significant consequences of this renal injury, we would have far less concern for the adequacy of follow-up. We next look at markers of renal injury and what tests are used in clinical practice to define contrast-induced nephropathy (CIN). Finally, we discuss the steps that should be taken in those who do develop CIN to limit the impact of the injury and protect them from future adverse events.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16612401     DOI: 10.1038/sj.ki.5000374

Source DB:  PubMed          Journal:  Kidney Int Suppl        ISSN: 0098-6577            Impact factor:   10.545


  13 in total

1.  A method for improving iodine contrast enhancement in abdominal computed tomography: experimental study in a pig model.

Authors:  Peter B Noël; Edgar Bendik; Daniela Münzel; Armin Schneider; Liran Goshen; Asher Gringauz; Yechiel Lamash; Alain Vlassenbroek; Alexander A Fingerle; Ernst J Rummeny; Martin Dobritz
Journal:  Eur Radiol       Date:  2012-10-19       Impact factor: 5.315

2.  High dose intracoronary N-acetylcysteine in a porcine model of ST-elevation myocardial infarction.

Authors:  Markus Meyer; Stephen P Bell; Zengyi Chen; Iwan Nyotowidjojo; Richard R Lachapelle; Timothy F Christian; Pamela C Gibson; Friederike F Keating; Harold L Dauerman; Martin M LeWinter
Journal:  J Thromb Thrombolysis       Date:  2013-11       Impact factor: 2.300

Review 3.  Contrast-induced nephropathy: pathogenesis and prevention.

Authors:  Robert E Cronin
Journal:  Pediatr Nephrol       Date:  2009-05-15       Impact factor: 3.714

4.  Risk of contrast-medium-induced nephropathy in high-risk patients undergoing MDCT--a pooled analysis of two randomized trials.

Authors:  Henrik S Thomsen; Sameh K Morcos
Journal:  Eur Radiol       Date:  2008-11-11       Impact factor: 5.315

5.  Renal safety in pediatric imaging: randomized, double-blind phase IV clinical trial of iobitridol 300 versus iodixanol 270 in multidetector CT.

Authors:  Martin Zo'o; Marcus Hoermann; Csilla Balassy; Francis Brunelle; Robin Azoulay; Danièle Pariente; Michel Panuel; Patrick Le Dosseur
Journal:  Pediatr Radiol       Date:  2011-06-29

6.  Early detection and intervention using neutrophil gelatinase-associated lipocalin (NGAL) may improve renal outcome of acute contrast media induced nephropathy: a randomized controlled trial in patients undergoing intra-arterial angiography (ANTI-CIN Study).

Authors:  Gernot Schilcher; Werner Ribitsch; Ronald Otto; Rupert H Portugaller; Franz Quehenberger; Martini Truschnig-Wilders; Robert Zweiker; Philipp Stiegler; Marianne Brodmann; Klemens Weinhandl; Joerg H Horina
Journal:  BMC Nephrol       Date:  2011-08-17       Impact factor: 2.388

7.  Novel biomarkers for contrast-induced acute kidney injury.

Authors:  Carlo Briguori; Cristina Quintavalle; Elvira Donnarumma; Gerolama Condorelli
Journal:  Biomed Res Int       Date:  2014-05-29       Impact factor: 3.411

8.  The role of inflammation in contrast-induced nephropathy.

Authors:  E A Kwasa; S Vinayak; R Armstrong
Journal:  Br J Radiol       Date:  2014-07-10       Impact factor: 3.039

9.  Contrast-induced nephropathy in patients undergoing intravenous contrast-enhanced computed tomography in Korea: a multi-institutional study in 101487 patients.

Authors:  Joongyub Lee; Jeong Yeon Cho; Hak Jong Lee; Yong Yeon Jeong; Chan Kyo Kim; Byung Kwan Park; Deuk Jae Sung; Byung Chul Kang; Sung Il Jung; Eun Ju Lee; Boem-Ha Yi; Seong Jin Park; Jong Chul Kim; Dae Chul Jung; Chang-Kyu Sung; Yongsoo Kim; Youngrae Lee; Sun Ho Kim; Seong Kuk Yoon; Byung-Joo Park; Seung Hyup Kim
Journal:  Korean J Radiol       Date:  2014-07-09       Impact factor: 3.500

10.  Effectiveness of N-Acetylcysteine for the Prevention of Contrast-Induced Nephropathy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Renfan Xu; Anyu Tao; Yang Bai; Youbin Deng; Guangzhi Chen
Journal:  J Am Heart Assoc       Date:  2016-09-23       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.